Empire Genomics
Biocare Medical Acquires Empire Genomics
The company believes its existing technology portfolio will be complemented by Empire's molecular probe business, better aiding cancer research and diagnostics.
Empire Genomics, Kromatid to Develop Tools for Detecting Cancer Genomic Structural Variations
The companies will combine Empire's NGS services and FISH probe portfolio with Kromatid's Pinpoint probes and directional genomic hybridization technology.
Empire Genomics Names HemaTone as China Distributor for Cancer Dx Products
Empire said it expects to generate $5 million or more in revenues from the Chinese market over the five-year term of the agreement with HemaTone.
Empire Genomics Nabs $1.8M Investment
The Buffalo, NY-based firm will use the proceeds to grow its marketing, automation, and operations, and to launch additional molecular diagnostic products.
New York State Grants Clinical Lab Permit to Empire Genomics
The permit will allow the company to offer DNA sequencing and molecular diagnostics for testing of cancer patients.
Dec 17, 2015
Empire Genomics Lands CE Mark for Several Products
Jan 5, 2015
Empire Genomics Acquires ID Labs
Jul 2, 2014
Empire Genomics Lands $1M Financing
Jun 5, 2013
New Next-gen Sequencing Facilities in New York
Nov 6, 2012
Jul 27, 2012
Mar 24, 2009